The Rates of Complete Symptom Relief,Prevetion of Symptom Relapse and Maintenance of Esophagitis Healing for 4-week Versus 8-week Esomeprazole Therapy Among Los Angeles Grades A and B Erosive Esophagitis
Phase of Trial: Phase IV
Latest Information Update: 18 May 2017
At a glance
- Drugs Esomeprazole (Primary)
- Indications Erosive oesophagitis
- Focus Therapeutic Use
- 13 Jul 2016 Status changed from recruiting to completed.
- 02 Nov 2015 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 02 Nov 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.